KLK3 and prostate cancer: In order to prove that, future mulitvariant analysis will be required to evaluate IL-33 mRNA/protein expression levels with clinicopathological variables which are currently used as important diagnostic features in prostate cancer, such as stage of disease, PSA level, and Gleason Score.